Financing of NCDs

Wednesday, 30.09.2015 | 09:00 - 11:00

Organised by World Health Organization

Non-communicable diseases: financing costs by public and private actors

The European region is the most affected by non-communicable diseases (NCDs) and their growth is startling. The impact of the major NCDs is alarming: taken together, these conditions account for an estimated 86% of deaths and 77% of the disease burden in the region.

The private sector needs to be part of effective multi-sectoral action on NCDs through various types of engagement. A balance of public and private contributions to prevention and control is one of the key components of a successful national NCD response. Governments can also make use of NGOs and academia in several important roles, including acting as a ‘bridge’ between government and the private sector.

This session will explore lessons learned from successful and unsuccessful examples of private sector engagement to date; and discuss its role in the effective multi-sectoral action on NCDs, including options ensuring due regard to real, perceived and potential conflicts of interest. We will also focus on domestic, bilateral and multilateral, and innovative financing of NCD prevention and control. Delegates will have the opportunity to explore how to use existing and new resources effectively to achieve maximum health impact from NCD prevention and control.

Opening and welcome

Oleg Chestnov, Assistant Director-General, NCD and Mental Health, World Health Organization

Financing national NCD responses – working with the private sector

Bente Mikkelsen, Head a.i. of the Secretariat for the WHO Global Coordination Mechanism on the Prevention and Control of NCDs

Access to pharmaceuticals in Albania and the need for working with the private sector

Ilir Beqaj, Minister of Health of Albania

Panel discussion

Morten Frank Pedersen, Executive Government Affairs Advisor, Novo Nordisk

Andrey Potapov, General Director, Head of the CIS Area, Takeda Pharmaceuticals LLC, Russian Federation

Pieter Dylst, Health Economics Officer, European Generic and Biosimilar Medicines Association (EGA)

Ketevan Goginashvili, Chief Specialist, Ministry of Health and Social Affairs, Georgia

Abdunamon Sidikov, International Cooperation Department, Ministry of Health, Uzbekistan


Matthias Wismar, Senior Health Policy Analyst, European Observatory on Health Systems and Policies

Willy Palm, Dissemination Development Officer, European Observatory on Health Systems and Policies

EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office